⌘K

Home/Filings/4/0000950170-25-020126

4//SEC Filing

Chawla Lakhmir S 4

Accession 0000950170-25-020126

CIK 0001810560other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 6:14 PM ET

Size

4.6 KB

Accession

0000950170-25-020126

Insider Transaction Report

Form 4

Period: 2025-02-11

REVELATION BIOSCIENCES, INC.REVB

Chawla Lakhmir S

Director

Transactions

Award
Common Stock
2025-02-11$3.87/sh+181$700→ 181 total

Footnotes (1)

[F1]Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

REVELATION BIOSCIENCES, INC.

CIK 0001810560

Entity typeother

Related Parties

1

filerCIK 0001646626

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 6:14 PM ET
Size: 4.6 KB

View on SEC.gov